IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 140 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $24,848,474,000 | +9.3% | 1,620,905 | -12.2% | 3.02% | +16.1% |
| Q1 2014 | $22,742,782,000 | +81.2% | 1,846,005 | +70.8% | 2.60% | +50.3% |
| Q4 2013 | $12,550,468,000 | -4.2% | 1,081,005 | -2.3% | 1.73% | -7.5% |
| Q3 2013 | $13,095,099,000 | +19.1% | 1,106,005 | -0.1% | 1.87% | -1.5% |
| Q2 2013 | $10,993,324,000 | – | 1,107,082 | – | 1.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |